EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 148 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.35 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $15,000 | -6.2% | 358 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $16,000 | -15.8% | 358 | +14.7% | 0.00% | 0.0% |
| Q4 2019 | $19,000 | +5.6% | 312 | -1.0% | 0.00% | 0.0% |
| Q3 2019 | $18,000 | 0.0% | 315 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $18,000 | +12.5% | 315 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $16,000 | +23.1% | 315 | 0.0% | 0.00% | +33.3% |
| Q4 2018 | $13,000 | -7.1% | 315 | +57.5% | 0.00% | -50.0% |
| Q3 2018 | $14,000 | +40.0% | 200 | 0.0% | 0.01% | +100.0% |
| Q3 2017 | $10,000 | -99.9% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $16,000,000 | +114185.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $14,000 | -56.2% | 200 | -92.0% | 0.00% | -50.0% |
| Q3 2014 | $32,000 | +23.1% | 2,500 | 0.0% | 0.01% | -57.1% |
| Q2 2014 | $26,000 | – | 2,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |